10-K Decoder · All companies

Arcutis Biotherapeutics, Inc.

ARQT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$376M$197M+91.3%
Operating income−$12.2M−$128M+90.5%
Net income−$16.1M−$140M+88.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$144M$99.2M+45.1%
Operating income$9.40M$8.50M+10.6%
Net income$8.80M$7.40M+18.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Arcutis's revenue in FY2025?
$376M in FY2025 (Fiscal year ended Dec 31, 2025), +91.3% vs $197M a year earlier, per its 10-K filed Feb 2026.
Was Arcutis profitable in FY2025?
No: net income was −$16.1M and operating income −$12.2M in FY2025.
What was Arcutis's revenue in Q3 2026?
$144M (+45.1% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.